The move underlines the company’s confidence in India’s expanding healthcare sector and its long-term commitment to strengthening access to quality medical services in major urban centers.

The acquisition will be carried out through Fortis Healthcare’s wholly owned subsidiary, International Hospital, by taking complete ownership of TMI Healthcare, the entity that operates People Tree Hospital.

This strategic transaction allows Fortis to seamlessly integrate the facility into its existing hospital network while maintaining operational continuity and clinical standards.

Bengaluru is one of India’s fastest-growing healthcare markets, driven by population growth, rising health awareness, and increasing demand for advanced medical care.

By adding People Tree Hospital to its portfolio, Fortis reinforces its presence in South India and positions itself to better serve patients across the city and neighboring regions.

Alongside the acquisition, Fortis has outlined plans to invest an additional 4.1 billion rupees over the next three years into the Bengaluru facility.

This investment is expected to focus on upgrading infrastructure, expanding capacity, enhancing medical technology, and strengthening clinical specialties to meet growing patient needs.

Company officials have highlighted that the transaction is expected to support revenue growth and improve profitability over time.

The integration of People Tree Hospital also complements Fortis’s broader strategy of consolidating high-quality healthcare assets in key metropolitan areas where demand for tertiary and quaternary care continues to rise.

Fortis Healthcare already operates a wide network of hospitals and healthcare facilities across multiple Indian states, offering services ranging from routine care to complex treatments.

The addition of a well-established Bengaluru hospital strengthens its ability to deliver comprehensive care while leveraging shared expertise, standardized processes, and operational efficiencies.

India’s healthcare sector is witnessing sustained investment as providers respond to demographic shifts, lifestyle-related diseases, and increased expectations for world-class treatment within the country.

Large hospital groups are increasingly focusing on expansion through both organic growth and targeted acquisitions to build scale and resilience.

The planned capital infusion into the newly acquired hospital reflects Fortis’s emphasis on long-term value creation rather than short-term gains.

Investments in advanced equipment, digital health solutions, and skilled medical professionals are expected to enhance patient outcomes and reinforce trust in the Fortis brand.

The company has also outlined a broader expansion roadmap, with significant capital earmarked for capacity additions in cities such as Bengaluru, Mumbai, the National Capital Region, and Punjab over the coming years. This indicates a balanced approach to growth, combining regional depth with national reach.

Healthcare analysts view such acquisitions as positive signals for the sector, as larger networks can improve efficiency, standardize care protocols, and invest more consistently in quality and safety.

For patients, this often translates into better access to specialized services and improved overall experience.

Overall, the acquisition of People Tree Hospital represents more than a single transaction.

It reflects Fortis Healthcare’s strategic vision to build a strong, future-ready healthcare network that can support India’s evolving medical needs while contributing to sustainable growth in one of the country’s most vital sectors.

The move positions IHH to increase its holding to approximately 57%, marking a significant milestone in its strategic expansion across India’s dynamic healthcare sector.

Investor optimism soars as IHH Healthcare secures regulatory approval for Fortis takeover, signaling strengthened healthcare presence and expansion across India.

IHH (IHHH.KL) climbed 3.1% to 8.38 ringgit ($1.99) on the Malaysian stock exchange, while Fortis (FOHE.NS) soared 6.7% to 1,045.95 rupees, outperforming domestic benchmarks. The gains underscore strong investor confidence and highlight the market’s positive reception of the deal, which has been eagerly anticipated since 2018.

The approval revives a strategic initiative that will strengthen IHH’s operational footprint and enhance healthcare delivery across India. By integrating Fortis’ 33 healthcare facilities, which house over 5,700 beds across 11 states, IHH is set to create a robust network offering high-quality, accessible healthcare to millions of patients nationwide.

Analysts view the approval as a key turning point for both companies. “This milestone signals IHH’s commitment to expanding its presence in India and supporting Fortis in reaching new heights in patient care, medical excellence, and operational efficiency,” noted Nursuhaiza Hashim, equity analyst at BIMB Securities Research.

The successful regulatory clearance is expected to foster long-term value creation for shareholders, employees, and the communities these hospitals serve.

The strategic move also highlights IHH’s growing international footprint. Operating more than 80 hospitals across 10 countries, including Malaysia, Singapore, Türkiye, and India, IHH continues to solidify its position as one of the world’s leading private healthcare providers. The addition of Fortis further strengthens its network, ensuring enhanced healthcare accessibility and world-class medical services across the region.

Fortis, renowned for its high standards in patient care, specialized services, and modern facilities, stands to benefit from IHH’s expertise in operational management and international healthcare best practices. The collaboration between these two healthcare leaders promises a new era of innovation, efficiency, and service quality in India’s growing healthcare market.

Investor enthusiasm reflects confidence in the potential for synergistic growth. Both IHH and Fortis shares have outperformed major indices, signaling strong market sentiment and faith in the long-term benefits of this strategic acquisition. The deal also represents a clear signal to global investors that India’s healthcare sector remains an attractive, high-growth market.

Looking ahead, the expanded IHH-Fortis network is expected to drive improvements in healthcare infrastructure, enhance patient experiences, and facilitate access to cutting-edge treatments and specialized care. The merger positions both companies to take advantage of India’s growing demand for quality healthcare services while delivering sustainable growth and value creation for stakeholders.

This landmark approval is more than just a regulatory milestone—it reflects IHH’s unwavering commitment to strengthening healthcare across India, delivering innovative solutions, and fostering a healthier future for communities nationwide. The strategic integration of Fortis into IHH’s global network demonstrates forward-looking leadership and sets the stage for continued growth and success in the region.

With a strengthened presence and growing capabilities, IHH Healthcare and Fortis are poised to elevate standards of healthcare delivery, ensuring patients across India benefit from world-class medical care while investors enjoy confidence in a robust, forward-looking healthcare ecosystem.